Literature DB >> 19755915

Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.

Jaganathan Subramani1, Kandaswamy Kathirvel, Marie Dennis Marcus Leo, Guruprasad Kuntamallappanavar, Thakur Uttam Singh, Santosh Kumar Mishra.   

Abstract

Sepsis has been reported to impair endothelium-dependent vasodilations mediated by nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF). Although some studies demonstrate that statins can improve NO-mediated response in septic animals, little is known about its effect on the EDHF response. The present study examined the effects of atorvastatin pretreatment on sepsis-induced endothelial dysfunctions and hypotension in rats. Eighteen hours after the induction of sepsis by cecal ligation and puncture, thoracic aorta and second generation pulmonary arteries were isolated to examine acetylcholine-induced endothelium-dependent dilations mediated by NO and EDHF, respectively. The messenger RNA (mRNA) expression for endothelial NO synthase (eNOS) and inducible NO synthase (iNOS) was done by real-time polymerase chain reaction. NO was measured as nitrate/nitrite release using Griess method. Mean arterial pressure was measured by the invasive method. Sepsis significantly decreased (26%) the relaxation response to acetylcholine in the rat aorta. It also markedly inhibited the eNOS mRNA expression and acetylcholine-stimulated NO release in this vessel. Pretreatment of the rats with atorvastatin (10 mg/kg, orally) 48, 24, and 2 hours before induction of sepsis preserved acetylcholine-induced relaxation, eNOS mRNA expression, acetylcholine-stimulated NO release, and attenuated increase in the inducible NO synthase mRNA expression and basal NO production in the aorta. The maximal EDHF response mediated by acetylcholine was 25.30% +/- 3.00% in the pulmonary artery. Sepsis abolished this response but atorvastatin restored it (22.55% +/- 2.50%). Atorvastatin, however, failed to prevent sepsis-induced hypotension. These results suggest that atorvastatin can restore impaired endothelium-dependent vasodilations mediated by NO and EDHF but not hypotension in sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755915     DOI: 10.1097/FJC.0b013e3181bfafd6

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Atorvastatin reduces endotoxin-induced microvascular inflammation via NOSII.

Authors:  Caroline C McGown; Zoë L S Brookes; Paul G Hellewell; Jonathan J Ross; Nicola J Brown
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-14       Impact factor: 3.000

2.  Luteolin alleviates vascular dysfunctions in CLP-induced polymicrobial sepsis in mice.

Authors:  Soya Rungsung; Thakur Uttam Singh; Kirthika Perumalraja; Archana Mahobiya; Meemansha Sharma; Madhu Cholenahalli Lingaraju; Subhashree Parida; Monalisa Sahoo; Dinesh Kumar
Journal:  Pharmacol Rep       Date:  2022-08-08       Impact factor: 3.919

3.  Statin therapy exacerbates alcohol-induced constriction of cerebral arteries via modulation of ethanol-induced BK channel inhibition in vascular smooth muscle.

Authors:  Maria N Simakova; Shivantika Bisen; Alex M Dopico; Anna N Bukiya
Journal:  Biochem Pharmacol       Date:  2017-09-01       Impact factor: 5.858

4.  Diosgenin improves vascular function by increasing aortic eNOS expression, normalize dyslipidemia and ACE activity in chronic renal failure rats.

Authors:  Jeganathan Manivannan; Elumalai Balamurugan; Thangarasu Silambarasan; Boobalan Raja
Journal:  Mol Cell Biochem       Date:  2013-08-23       Impact factor: 3.396

5.  Effect of statin use on outcomes of adults with candidemia.

Authors:  Guillermo Cuervo; Carolina Garcia-Vidal; Marcio Nucci; Francesc Puchades; Mario Fernández-Ruiz; Analía Mykietiuk; Adriana Manzur; Carlota Gudiol; Javier Pemán; Diego Viasus; Josefina Ayats; Jordi Carratalà
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

6.  Effects of atorvastatin combined with low-molecular-weight heparin on plasma inflammatory cytokine level and pulmonary pathophysiology of rats with sepsis.

Authors:  Fei Jing; Ming Li; Hongsheng Ren; Jitian Zhang; Qingchun Yao; Yufeng Chu; Chunting Wang
Journal:  Exp Ther Med       Date:  2016-05-20       Impact factor: 2.447

7.  Coexistence of Lack of Clinical Manifestation of Oral Mycosis and Systemic Diseases in Edentulous Patients Using Removable Prosthetic Restorations.

Authors:  Izabela Gacon; Aneta Wieczorek
Journal:  Int J Environ Res Public Health       Date:  2020-08-31       Impact factor: 3.390

8.  Effects of statins on the development of sepsis and organ dysfunction in hospitalized older patients in China.

Authors:  Qifeng Gui; Yunmei Yang; Jiajia Zhang
Journal:  Braz J Infect Dis       Date:  2017-03-07       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.